UroGen Pharma Ltd. (URGN)
36.83
-0.15
(-0.41%)
USD |
NASDAQ |
Oct 09, 16:00
36.83
0.00 (0.00%)
After-Hours: 20:00
UroGen Pharma Market Cap : 1.800B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.807B |
| October 07, 2026 | 1.989B |
| October 06, 2026 | 2.025B |
| October 05, 2026 | 2.091B |
| October 02, 2026 | 2.023B |
| October 01, 2026 | 1.982B |
| September 30, 2026 | 1.986B |
| September 29, 2026 | 1.977B |
| September 28, 2026 | 1.999B |
| September 25, 2026 | 2.021B |
| September 24, 2026 | 2.015B |
| September 23, 2026 | 2.034B |
| September 22, 2026 | 2.090B |
| September 21, 2026 | 2.111B |
| September 18, 2026 | 2.114B |
| September 17, 2026 | 2.148B |
| September 16, 2026 | 2.125B |
| September 15, 2026 | 2.040B |
| September 14, 2026 | 2.084B |
| September 11, 2026 | 2.068B |
| September 10, 2026 | 2.064B |
| September 09, 2026 | 2.199B |
| September 08, 2026 | 2.141B |
| September 04, 2026 | 2.155B |
| September 03, 2026 | 2.193B |
| Date | Value |
|---|---|
| September 02, 2026 | 2.171B |
| September 01, 2026 | 2.120B |
| August 31, 2026 | 2.106B |
| August 28, 2026 | 2.132B |
| August 27, 2026 | 2.224B |
| August 26, 2026 | 2.245B |
| August 25, 2026 | 2.266B |
| August 24, 2026 | 2.256B |
| August 21, 2026 | 2.290B |
| August 20, 2026 | 2.287B |
| August 19, 2026 | 2.458B |
| August 18, 2026 | 2.391B |
| August 17, 2026 | 2.401B |
| August 14, 2026 | 2.356B |
| August 13, 2026 | 2.352B |
| August 12, 2026 | 2.395B |
| August 11, 2026 | 2.302B |
| August 10, 2026 | 2.263B |
| August 07, 2026 | 2.295B |
| August 06, 2026 | 2.228B |
| August 05, 2026 | 2.269B |
| August 04, 2026 | 1.951B |
| August 03, 2026 | 1.886B |
| July 31, 2026 | 1.863B |
| July 30, 2026 | 2.001B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xencor, Inc. | 1.828B |
| MeiraGTx Holdings Plc | 1.007B |
| Insmed, Inc. | 21.97B |
| Ironwood Pharmaceuticals, Inc. | 629.56M |
| Viking Therapeutics, Inc. | 3.323B |
Market Cap Related Metrics
| PS Ratio | 9.609 |
| Price | 36.83 |
| Earnings Yield | -5.41% |